Thierry Levade Selected Research

beta-Mannosidosis (beta-Mannosidase Deficiency)

9/2009	A MANBA mutation resulting in residual beta-mannosidase activity associated with severe leukoencephalopathy: a possible pseudodeficiency variant.
1/2009	Beta-mannosidosis: a new cause of spinocerebellar ataxia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thierry Levade Research Topics

Disease

36	Neoplasms (Cancer) 12/2023 - 05/2003
24	Melanoma (Melanoma, Malignant) 12/2023 - 06/2003
15	Farber Lipogranulomatosis 06/2024 - 11/2008
9	Gaucher Disease (Gaucher's Disease) 03/2024 - 10/2012
8	Lysosomal Storage Diseases (Lysosomal Storage Disease) 04/2024 - 09/2009
5	Inborn Genetic Diseases (Disease, Hereditary) 01/2023 - 05/2004
5	Starvation 11/2011 - 03/2006
4	Insulin Resistance 06/2024 - 02/2012
4	Nervous System Diseases (Neurological Disorders) 01/2023 - 09/2009
4	Inflammation (Inflammations) 01/2022 - 11/2009
3	Mucopolysaccharidoses 04/2024 - 01/2018
3	Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy) 01/2023 - 01/2018
3	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2023 - 01/2018
3	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 01/2023 - 09/2009
3	Infections 02/2016 - 01/2009
3	Leukemia 04/2012 - 01/2011
3	Heart Failure 09/2007 - 01/2004
2	Glucose Intolerance 06/2024 - 10/2023
2	Non-alcoholic Fatty Liver Disease 10/2023 - 01/2022
2	GM1 Gangliosidosis (Gangliosidosis GM1) 01/2023 - 01/2023
2	Sphingolipidoses (Sphingolipidosis) 10/2022 - 01/2017
2	Ataxia (Dyssynergia) 01/2022 - 11/2006
2	Niemann-Pick Diseases (Niemann Pick Disease) 10/2021 - 01/2011
2	Skin Neoplasms (Skin Cancer) 11/2020 - 01/2019
2	Fabry Disease (Fabry's Disease) 01/2017 - 06/2009
2	Refsum Disease (Refsum's Disease) 01/2015 - 11/2006
2	Obesity 08/2014 - 02/2012
2	Alcoholic Fatty Liver 02/2013 - 11/2009
2	Necrosis 02/2013 - 12/2002
2	Weight Loss (Weight Reduction) 02/2013 - 11/2009
2	Infarction (Infarctions) 10/2012 - 09/2007
2	Lymphoid Leukemia 03/2011 - 01/2011
2	beta-Mannosidosis (beta-Mannosidase Deficiency) 09/2009 - 01/2009
1	Mucopolysaccharidosis III (Sanfilippo Syndrome) 04/2024

Drug/Important Bio-Agent (IBA)

31	CeramidesIBA 06/2024 - 06/2003
30	SphingolipidsIBA 12/2023 - 12/2002
22	EnzymesIBA 04/2024 - 05/2003
16	Acid CeramidaseIBA 06/2024 - 04/2007
10	LipidsIBA 01/2023 - 02/2009
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2019 - 12/2002
7	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 12/2023 - 12/2009
7	Proteins (Proteins, Gene)FDA Link 01/2018 - 05/2004
6	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 01/2021 - 01/2004
5	Glucosylceramidase (Glucocerebrosidase)IBA 09/2023 - 06/2016
4	LigandsIBA 06/2024 - 01/2003
4	AcidsIBA 09/2023 - 01/2004
4	GangliosidesIBA 01/2023 - 11/2011
4	CholesterolIBA 01/2023 - 09/2009
4	SphingomyelinsIBA 10/2021 - 05/2012
4	ceramide glucosyltransferaseIBA 02/2020 - 06/2003
4	Glucosylceramides (Glucocerebrosides)IBA 02/2020 - 05/2012
4	SphingosineIBA 02/2020 - 05/2003
4	sphingosine kinaseIBA 01/2020 - 09/2005
4	AntibodiesIBA 11/2019 - 11/2002
4	CytokinesIBA 01/2017 - 01/2009
3	CeramidasesIBA 06/2024 - 08/2011
3	GalactosidasesIBA 04/2024 - 01/2022
3	Polysaccharides (Glycans)IBA 04/2024 - 01/2011
3	PyrrolidinesIBA 03/2024 - 01/2019
3	Choline (Choline Chloride)IBA 01/2022 - 11/2009
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 11/2009
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
3	phosphatidylcholine-ceramide phosphocholine transferaseIBA 01/2019 - 05/2012
3	Lysergic Acid Diethylamide (LSD)IBA 01/2018 - 11/2008
3	Fas Ligand Protein (Fas Ligand)IBA 01/2017 - 04/2009
3	CaspasesIBA 01/2017 - 11/2002
3	HydrolasesIBA 06/2016 - 12/2004
3	Triglycerides (Triacylglycerol)IBA 02/2013 - 11/2009
2	Amino Acids FDA Link 10/2023 - 05/2009
2	GlucosidasesIBA 09/2023 - 02/2013
2	miglustat (Zavesca)FDA Link 01/2023 - 06/2003
2	NucleotidesIBA 01/2023 - 11/2010
2	Tumor Necrosis Factor InhibitorsIBA 01/2021 - 11/2019
2	Infliximab (Remicade)FDA Link 01/2021 - 11/2019
2	Fatty Acids (Saturated Fatty Acids)IBA 10/2020 - 02/2012
2	Immune Checkpoint InhibitorsIBA 01/2020 - 11/2019
2	Caspase 9IBA 01/2017 - 04/2012
2	Phytanic AcidIBA 01/2015 - 11/2006
2	GlycosphingolipidsIBA 02/2013 - 09/2009
2	Methionine (L-Methionine)FDA Link 02/2013 - 11/2009
2	Alanine Transaminase (SGPT)IBA 02/2013 - 11/2009
2	Plant LectinsIBA 03/2011 - 01/2011
2	Photosensitizing Agents (Photosensitizers)IBA 03/2011 - 01/2011
2	PorphyrinsIBA 03/2011 - 01/2011
2	AntigensIBA 03/2011 - 01/2011
2	5- (4- (5- carboxy- 1- butoxy)phenyl)- 10,15,20- tris(4- N- methyl)pyridiniumylporphyrinIBA 03/2011 - 01/2011
2	LyasesIBA 04/2010 - 12/2009
2	beta-MannosidaseIBA 09/2009 - 01/2009
2	alpha-Galactosidase (Beano)IBA 06/2009 - 01/2006
2	Beclin-1IBA 05/2009 - 03/2006
1	AdiponectinIBA 06/2024
1	Adiponectin ReceptorsIBA 06/2024
1	Neutral CeramidaseIBA 06/2024
1	Cathepsin AIBA 04/2024
1	Neuraminidase (Sialidase)IBA 04/2024
1	GlycosaminoglycansIBA 04/2024

Therapy/Procedure

14	Therapeutics 01/2023 - 04/2006
6	Drug Therapy (Chemotherapy) 02/2020 - 04/2007
4	Immunotherapy 11/2019 - 10/2018
2	Photochemotherapy (Photodynamic Therapy) 03/2011 - 01/2011